Current Portfolio
Phagenesis
Phagenesis develops the Phagenyx system, a device delivering targeted electrical stimulation to treat neurogenic dysphagia. Its therapy helps restore swallowing function and reduce complications in patients after stroke or neurological disease.
Key Facts
- Sector
Life Sciences
- Country
United Kingdom
- Fund
EQT HE 3
- Entry
2024
Website
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.